These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19999737)

  • 61. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 62. Role of the distal hinge region of C1-inhibitor in the regulation of C1s activity.
    He S; Yang JC; Tsang S; Sim RB; Whaley K
    FEBS Lett; 1997 Aug; 412(3):506-10. PubMed ID: 9276455
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity.
    Arlaud GJ; Gaboriaud C; Thielens NM; Budayova-Spano M; Rossi V; Fontecilla-Camps JC
    Mol Immunol; 2002 Nov; 39(7-8):383-94. PubMed ID: 12413689
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activation of the first component of human complement (C1) by antibody-antigen aggregates.
    Dodds AW; Sim RB; Porter RR; Kerr MA
    Biochem J; 1978 Nov; 175(2):383-90. PubMed ID: 743203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C1 inhibitor: analysis of the role of amino acid residues within the reactive center loop in target protease recognition.
    Zahedi R; MacFarlane RC; Wisnieski JJ; Davis AE
    J Immunol; 2001 Aug; 167(3):1500-6. PubMed ID: 11466370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calcium-sensitive thermal transitions and domain structure of human complement subcomponent C1r.
    Busby TF; Ingham KC
    Biochemistry; 1987 Aug; 26(17):5564-71. PubMed ID: 2823884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structural biology of C1.
    Arlaud GJ; Gaboriaud C; Thielens NM; Rossi V
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1001-6. PubMed ID: 12440961
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structure and activation of C1, the complex initiating the classical pathway of the complement cascade.
    Mortensen SA; Sander B; Jensen RK; Pedersen JS; Golas MM; Jensenius JC; Hansen AG; Thiel S; Andersen GR
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):986-991. PubMed ID: 28104818
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Electron microscope studies of C1s, C1s2, C1r2, C1r2C1s2 and C1-inhibitor.
    Schumaker VN; Phillips ML
    Behring Inst Mitt; 1993 Dec; (93):17-24. PubMed ID: 8172564
    [No Abstract]   [Full Text] [Related]  

  • 71. The initiating proteases of the complement system: controlling the cleavage.
    Duncan RC; Wijeyewickrema LC; Pike RN
    Biochimie; 2008 Feb; 90(2):387-95. PubMed ID: 17850949
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unique C1 inhibitor dysfunction in a kindred without angioedema. I. A mutant C1 INH that inhibits C1-s but not C1-r.
    Wisnieski JJ; Knauss TC; Yike I; Dearborn DG; Narvy RL; Naff GB
    J Immunol; 1994 Mar; 152(6):3199-209. PubMed ID: 8144914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A secondary C1s interaction site on C1-inhibitor is essential for formation of a stable enzyme-inhibitor complex.
    He S; Sim RB; Whaley K
    FEBS Lett; 1997 Mar; 405(1):42-6. PubMed ID: 9094421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Activation of Cl, the first component of complement, the generation of Clr-Cls and Cl- inactivator complexes in normal serum by heparin-affinity chromatography.
    McKay EJ; Laurell AB; Mårtensson U; Sjöholm AG
    Mol Immunol; 1981 May; 18(5):349-57. PubMed ID: 6273714
    [No Abstract]   [Full Text] [Related]  

  • 76. Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19.
    Thiel S; Petersen SV; Vorup-Jensen T; Matsushita M; Fujita T; Stover CM; Schwaeble WJ; Jensenius JC
    J Immunol; 2000 Jul; 165(2):878-87. PubMed ID: 10878362
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deficiency of serum C1 subcomponents and low functional activity of C1- inhibitor in a patient with urticaria and cryoglobulinemia.
    Lamas AM; Arnold PI; Schultz DR
    Am J Med; 1992 Apr; 92(4):445-6. PubMed ID: 1558093
    [No Abstract]   [Full Text] [Related]  

  • 78. Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process.
    Arlaud GJ; Reboul A; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):227-35. PubMed ID: 303116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Demonstration and quantitation of activation of the first component of complement in human serum.
    Ziccardi RJ; Cooper NR
    J Exp Med; 1978 Feb; 147(2):385-95. PubMed ID: 75238
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic studies of low-abundance human plasma proteins. XI. Linkage analysis and population genetics of the C1S subcomponent of the first complement component.
    Lyons LA; Kamboh MI; Ferrell RE
    Complement Inflamm; 1989; 6(2):81-7. PubMed ID: 2541966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.